GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jushi Holdings Inc (OTCPK:JUSHF) » Definitions » Revenue

JUSHF (Jushi Holdings) Revenue : $259.4 Mil (TTM As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Jushi Holdings Revenue?

Jushi Holdings's revenue for the three months ended in Sep. 2024 was $61.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $259.4 Mil. Jushi Holdings's Revenue per Share for the three months ended in Sep. 2024 was $0.32. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $1.33.

Warning Sign:

Jushi Holdings Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Jushi Holdings was -6.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Jushi Holdings's highest 3-Year average Revenue per Share Growth Rate was 24.80% per year. The lowest was 24.80% per year. And the median was 24.80% per year.


Jushi Holdings Revenue Historical Data

The historical data trend for Jushi Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jushi Holdings Revenue Chart

Jushi Holdings Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 80.77 209.29 284.28 269.45

Jushi Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.38 67.77 65.46 64.60 61.61

Competitive Comparison of Jushi Holdings's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jushi Holdings's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Jushi Holdings's Revenue falls into.



Jushi Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $259.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jushi Holdings  (OTCPK:JUSHF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Jushi Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Jushi Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Jushi Holdings Business Description

Traded in Other Exchanges
Address
301 Yamato Road, Suite 3250, Boca Raton, FL, USA, 33431
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals, and competitive applications. Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, including its brands, The Lab: Concentrates and The Bank: Flower + Genetics, as well as its precision-formulated line of medical cannabis products Nira Plus. Jushi strives to maximize shareholder value while delivering high-premium products across all levels of the cannabis and hemp ecosystem.